arrow
E

Eva González-Barca

Institut Català d'Oncologia
H指数:44
被引数:7,159

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TAFASITAMAB PLUS LENALIDOMIDE AS SALVAGE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: REAL-WORLD EXPERIENCE FROM GELTAMO

妥英珠单抗联合来那度胺作为弥漫性大B细胞淋巴瘤的挽救治疗:GELTAMO的真实世界经验

2025-07-180
OAAI
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma

通过全外显子测序对弥漫性大B细胞淋巴瘤和浆细胞样淋巴瘤进行遗传亚型分型

2025-03-110
OA
Effect of Consolidation with Allogeneic Hematopoietic Cell Transplant Versus No Consolidation in Patients with Non-Hodgkin Lymphomas Treated with Bispecific Antibodies

同种异基因造血细胞移植巩固治疗与无巩固治疗对接受双特异性抗体治疗的非霍奇金淋巴瘤患者的影响

BLOOD
IF23.1
2024-11-050
PRE
Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL
2024-10-070
OAAI
Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes
2024-07-112
OAAI
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
2024-02-013
PRE
Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage
2024-02-010
OAAI
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
2023-03-164
OA
Expert Consensus on the Characteristics of Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study

关于epstein-barr病毒阳性的移植后淋巴增生性疾病 (EBV PTLD) 患者的特征的专家共识,标准剂量化疗可能不合适: 一项改良的Delphi研究

2023-01-210
OAAI
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
2022-10-046
OAAI
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
2022-09-0911
OA
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)

真实使用头孢特咯瓒/他唑巴坦治疗中性粒细胞减少性血液病患者铜绿假单胞菌引起的血流感染: 一项配对对照研究 (ZENITH研究)

2022-06-2919
OAAI
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
2021-11-2227
OAAI